Back

Alteration of skin fibroblast steady state contributes to healing outcomes

Huang, Y.; Wang, N.; Xing, H.; Tian, J.; Zhang, D.; Gao, D.; Hsia, H. C.-h.; Lu, J.; Raredon, M. S. B.; Kyriakides, T.

2024-12-12 pathology
10.1101/2024.12.06.627278 bioRxiv
Show abstract

Fibroblasts display complex functions associated with distinct gene expression profiles that influence matrix production and cell communications and the autonomy of tissue development and repair. Thrombospondin-2 (TSP-2), produced by fibroblasts, is a potent angiogenesis inhibitor and negatively associated with tissue repair. Single-cell (sc) sequencing analysis on WT and TSP2KO skin fibroblasts demonstrate distinct cell heterogeneity. Specifically, we found an enrichment of Sox10+ multipotent progenitor cells, identified as Schwann precursor cells, in TSP2KO fibroblasts, while fibrosis-related subpopulations decreased. Immunostaining of tissue and cells validated the increase of this Sox10+ population in KO fibroblasts. Furthermore, in silico analysis suggested enhanced pro-survival signaling, including WNT, TGF-{beta}, and PDGF-{beta}, alongside a reduced BMP4 response. Additionally, the creation of two TSP2KO NIH3T3 cell lines using the CRISPR/Cas9 technique allowed functional and signaling validation in a less complex system. Moreover, KO 3T3 cells exhibited enhanced migration and proliferation, with elevated levels of pro-regenerative molecules including TGF-{beta}3 and Wnt4, and enrichment of nuclear {beta}-catenin. These functional and molecular alterations likely contribute to improved healing and increased neurogenesis in TSP2-deficient wounds. Overall, our findings describe the heterogeneity of dermal fibroblasts and identify pro-regenerative features of TSP2KO fibroblasts.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
The Journal of Pathology
26 papers in training set
Top 0.1%
15.4%
2
The FASEB Journal
194 papers in training set
Top 0.1%
9.1%
3
Matrix Biology Plus
10 papers in training set
Top 0.1%
8.0%
4
PLOS ONE
5266 papers in training set
Top 28%
5.6%
5
Scientific Reports
3612 papers in training set
Top 15%
5.6%
6
International Journal of Molecular Sciences
494 papers in training set
Top 2%
4.1%
7
Journal of Investigative Dermatology
49 papers in training set
Top 0.2%
3.3%
50% of probability mass above
8
JCI Insight
277 papers in training set
Top 2%
3.3%
9
Cancers
213 papers in training set
Top 2%
2.7%
10
Journal of Cellular and Molecular Medicine
20 papers in training set
Top 0.2%
1.9%
11
Matrix Biology
29 papers in training set
Top 0.2%
1.9%
12
Cells
249 papers in training set
Top 3%
1.7%
13
eLife
5828 papers in training set
Top 53%
1.5%
14
Biomolecules
100 papers in training set
Top 1%
1.4%
15
iScience
1154 papers in training set
Top 24%
1.1%
16
The American Journal of Pathology
32 papers in training set
Top 0.5%
1.1%
17
FEBS Letters
47 papers in training set
Top 0.3%
1.1%
18
International Journal of Biological Sciences
10 papers in training set
Top 0.1%
1.1%
19
European Journal of Immunology
60 papers in training set
Top 1.0%
1.1%
20
Biomedicines
67 papers in training set
Top 2%
1.1%
21
The FEBS Journal
93 papers in training set
Top 1%
1.1%
22
Stem Cell Research & Therapy
30 papers in training set
Top 0.5%
1.1%
23
Nature Communications
5641 papers in training set
Top 53%
1.1%
24
Life Sciences
27 papers in training set
Top 0.9%
1.0%
25
Stem Cell Reports
130 papers in training set
Top 2%
1.0%
26
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 4%
0.9%
27
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.9%
28
PLOS Pathogens
820 papers in training set
Top 9%
0.9%
29
Journal of Translational Medicine
57 papers in training set
Top 3%
0.6%
30
Cell Death & Disease
126 papers in training set
Top 4%
0.6%